Effects of combination drugs of calcium channel blockers and angiotensin II receptor blockers on blood pressure, lipid profile, and glucose metabolism in hypertensive patients with glucose intolerance.

Trial Profile

Effects of combination drugs of calcium channel blockers and angiotensin II receptor blockers on blood pressure, lipid profile, and glucose metabolism in hypertensive patients with glucose intolerance.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Amlodipine (Primary) ; Candesartan cilexetil (Primary) ; Telmisartan (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms J-METS
  • Most Recent Events

    • 07 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top